QC Bioassay Analyst III at Gilead Sciences

Cork, County Cork, Ireland

Gilead Sciences Logo
Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, PharmaceuticalsIndustries

Requirements

  • Experience with analytical techniques such as Cell Culture, ELISA, Receptor Binding and Cell-based assays
  • Previous Industry experience
  • Working knowledge of GMPs, GLPs, and regulatory requirements for Biologics testing
  • Advanced skills in proper aseptic techniques and behaviours
  • Knowledge of software such as Softmax Pro, LIMS
  • Excellent communication skills (both verbal and technical) - demonstrates the ability to clearly and concisely present/explain tests, analysis, and outcomes to multiple audiences
  • Excellent interpersonal skills and ability to work effectively with people from a wide range of skill levels and experience
  • Ability to work independently and as part of a team with internal and external partners
  • Experience in method validation/method transfers (advantage)

Responsibilities

  • Proficiently execute Bioassay techniques such as ELISA, Receptor Binding and Cell-based assays
  • Participation in analytical method transfers/method validations
  • Develop subject matter expertise on assigned analytical techniques
  • Review data and results of testing to ensure compliance to appropriate specifications and protocols
  • Demonstrate skills in data analysis and ability to critically evaluate data quality
  • Lead Bioassay investigations/troubleshooting and technical projects within the function
  • Provision of technical support for investigations and optimisation projects
  • Deliver new technologies and continuous improvement initiatives to meet business requirements
  • Execute protocols and reports
  • Develop, revise, and implement procedures that comply with appropriate regulatory requirements
  • Execute analysis efficiently, consistently, and with high quality
  • Interface with key cross functional stakeholders locally and across the Gilead network
  • Work on non-routine projects and assignments
  • Quality control testing, analytical method transfers, new product introductions and technical investigations to support GMP operations

Skills

ELISA
Receptor Binding
Cell-based assays
Analytical method transfers
Method validations
Data analysis
GMP
Bioassay
Technical investigations
Troubleshooting

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters
1987Year Founded
$15,873.6MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Paid family time off and paid parental time off
Generous 401(k) contribution matching
Comprehensive medical plans that cover both physical and mental healthcare
Global Wellbeing Reimbursement
Time Off
Global Volunteer Day
Giving Together Program
Employee Support Programs
Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.
Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.
Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.
Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.
Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.
Investment in digital health technologies enhances Gilead's R&D and patient engagement.
Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI